Suzhou Alphamab Co., Ltd.

This study is testing whether a new injection called KN057 can safely prevent bleeding episodes in people with hemophilia A or B. The trial involves 125 male participants aged 12-70 who currently experience frequent bleeds. Researchers will compare how often bleeds occur with KN0…

This study is testing whether a new injection called KN057 can safely prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors, which make standard treatments less effective. About 53 male participants aged 12-70 will be randomly assigned to receiv…

This study is testing whether a new drug called KN060 works better than the standard medication (enoxaparin) at preventing dangerous blood clots in people having total knee replacement surgery. Researchers are comparing different doses of KN060 in 241 patients to see how well it …